FDA speeds up review of Roches Tecentriq to treat another bladder cancer supriya14 Jan 2017 9:27 AM ISTRoche said that U.S. regulators agreed to priority review of its Tecentriq immunotherapy for an additional type of bladder cancer, a boost to the...
Pharma, biotech stocks topple on Trump's speech supriya kashyap kashyap13 Jan 2017 2:23 PM ISTNew York : Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new...
Hikal up 11 pc on successful USFDA inspection supriya13 Jan 2017 2:19 PM ISTNew Delhi : Shares of pharma firm Hikal Ltd surged 11.5 per cent after the company said its active pharmaceutical ingredients and intermediates...
Japan's Takeda to buy US cancer drug maker Ariad in $5.2 billion deal supriya13 Jan 2017 2:18 PM ISTJapan's Takeda Pharmaceutical Co Ltd said it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion, to beef up its...
Eli Lilly defeats Teva appeal over Alimta cancer drug supriya kashyap kashyap13 Jan 2017 2:17 PM ISTA U.S. appeals court said Eli Lilly and Co may block Teva Pharmaceutical Industries Ltd from selling a generic equivalent of its top-selling lung...
Daiichi Sankyo closes RnD Division in India savita thakur thakur12 Jan 2017 1:11 PM ISTMUMBAI: Daiichi Sankyo India Pharma Pvt. Ltd. (DSIN), an organization working in the field of innovative pharmaceutical Research & Development...
USFDA Accepts BLA for Mylan and Biocon's Proposed Biosimilar Trastuzumab supriya12 Jan 2017 11:22 AM ISTBengaluru : Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration has accepted Mylan's biologics license application (BLA)...
AbbVie vows to keep drug price increases below 10 percent supriya12 Jan 2017 11:20 AM ISTAbbVie Inc Chief Executive Richard Gonzalez promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drug maker...
Merck leapfrogs rivals in lung cancer drug combination race supriya12 Jan 2017 11:19 AM ISTMerck & Co has pulled ahead of rivals in the race to combine immunotherapy with other drugs as a treatment for lung cancer, potentially giving it...
Intas Pharmaceuticals Completes Deal to Acquire Actavis UK,Ireland Generics Businesses From Teva supriya11 Jan 2017 11:09 AM ISTAhmedabad : Intas Pharmaceuticals Ltd. through its wholly-owned subsidiary Accord Healthcare Ltd. announced it has completed the deal to acquire...
FDA Grants Bayer Priority Review for Stivarga-regorafeni for the Second-Line Systemic Treatment of Liver Cancer supriya11 Jan 2017 11:08 AM ISTWhippany : Bayer announced that the U.S. Food and Drug Administration (FDA) has granted priority review status for the supplemental New Drug...
OmniActive Health acquires 85 percent stake in Indfrag supriya11 Jan 2017 11:06 AM ISTNew Delhi : OmniActive Health Technologies, which supplies ingredients to the healthcare and food industries, has acquired 85 per cent stake in...
